Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)

NACompletedINTERVENTIONAL
Enrollment

2,978

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

March 30, 2024

Conditions
MalariaMalaria,Falciparum
Interventions
OTHER

Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT

Standard approach for SMC strategy used by the Ministry of Health (without directly-observed therapy) and without any interference of the study team. Implemented over 4 rounds, carried out in June-October 2023 with \~30 days between rounds.

OTHER

Seasonal Malaria Chemoprophylaxis (under 5 years old) with DOT

SMC will be implemented with the same number of rounds and the same timing as in active comparator arm but village health workers will visit the participants at home to administer each dose of study treatment (with DOT-directly-observed therapy)

OTHER

Seasonal Malaria Chemoprophylaxis (under 10 years old) with DOT

SMC will be implemented as in arm 2 but age of participants is extended up to 10 years: each dose of study treatment (with DOT-directly-observed therapy) distributed at home by village health workers.

Trial Locations (1)

Unknown

Groupe de Recherche Action en Santé, Ouagadougou

All Listed Sponsors
collaborator

Groupe de Recherche Action en Sante

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER